| Feb 10 2025 |
DOJ Narrows FCPA Enforcement Focus |
Womble Bond Dickinson (US) LLP |
| Feb 10 2025 |
Not Cool, Man: Senate Proposal to Expand 280E Taxes on Cannabis Businesses Even if Rescheduled |
Bradley Arant Boult Cummings LLP |
| Feb 10 2025 |
Proposed FDA Rule May Require Stricter Testing for Talc in Cosmetic Products |
CMBG3 Law |
| Feb 9 2025 |
Senate HELP Committee Shares Health and Retirement Plan Legislative Priorities |
Jones Walker LLP |
| Feb 7 2025 |
McDermott+ Check-Up: February 7, 2025 |
McDermott Will & Emery |
| Feb 7 2025 |
Finally, FDA’s Final Word on Unapproved Use Communications |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 7 2025 |
Key Takeaways on New U.S. Tariffs on Canada, China and Mexico Imports |
Barnes & Thornburg LLP |
| Feb 7 2025 |
MA Cannabis Commission Releases New HCA Resources |
Blank Rome LLP |
| Feb 6 2025 |
The New Administration and Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Developments — A Conversation with Jim Aidala [Podcast] |
Bergeson & Campbell, P.C. |
| Feb 6 2025 |
EPA Releases Third Triennial Report to Congress on Biofuels and the Environment |
Bergeson & Campbell, P.C. |
| Feb 6 2025 |
Eye-Catching: Biosimilars Injunction Prevails |
McDermott Will & Emery |
| Feb 6 2025 |
New PTAB Guidance on Enabling Requirement Under § 102 of the AIA and Construction of Chemical Compound |
Polsinelli PC |
| Feb 6 2025 |
Legislators Introduce Feed Lot Testing Bill |
Keller and Heckman LLP |
| Feb 6 2025 |
From the Year of the Dragon to the Year of the Snake: China’s Food Law Year-in-Review 2024 |
Keller and Heckman LLP |
| Feb 6 2025 |
Bill Proposed to Block USDA from Using Funds to Implement Proposed Salmonella Framework |
Keller and Heckman LLP |
| Feb 5 2025 |
Biden USDA Issues Technical Guidelines for Climate-Smart Agriculture Crops Used as Biofuel Feedstocks |
Bergeson & Campbell, P.C. |
| Feb 5 2025 |
This Week in 340B: January 28 – February 3, 2025 |
McDermott Will & Emery |
| Feb 4 2025 |
House Committee Will Hold Hearing on “The State of U.S. Science and Technology: Ensuring U.S. Global Leadership” |
Bergeson & Campbell, P.C. |
| Feb 3 2025 |
REBO Quarterly: 2024 in Retrospect |
K&L Gates LLP |
| Feb 3 2025 |
Tariffs on Mexico, Canada Paused for 30 Days |
Miller Canfield |
| Feb 3 2025 |
Wearable Technologies and Employment Risks – EEOC Issues New Guidance |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 3 2025 |
New Tariffs on U.S. Imports from Canada, Mexico, and China |
Polsinelli PC |
| Feb 3 2025 |
The Trade War Begins with Canada, China, and Mexico |
Miller Canfield |
| Feb 3 2025 |
FDA & OHRP Draft Guidance: Including Tissue Biopsies in Clinical Trials |
Foley & Lardner LLP |
| Jan 31 2025 |
EC Launches Biotech and Biomanufacturing Hub to Support Innovative Companies |
Bergeson & Campbell, P.C. |
| Jan 31 2025 |
2025 Top-of-Mind Issues for Life Sciences Companies |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 31 2025 |
McDermott+ Check-Up: January 31, 2025 |
McDermott Will & Emery |
| Jan 31 2025 |
FDA Releases Draft Guidance on AI-Enabled Medical Devices |
Greenberg Traurig, LLP |
| Jan 31 2025 |
Federal Appeals Court Holds New Jersey’s Cannabis Law Provides No Private Right of Action |
Jackson Lewis P.C. |
| Jan 30 2025 |
Bottling the Truth: Equivalence and Reverse Equivalence |
McDermott Will & Emery |
| Jan 29 2025 |
FDA Develops Strategy to Prevent Adulteration of Berries with Enteric Viral Infections |
Keller and Heckman LLP |
| Jan 29 2025 |
President Trump Enacts Regulatory Freeze and Halts Public Communications for Federal Agencies |
Keller and Heckman LLP |
| Jan 29 2025 |
N.J. Appellate Division Applies TOA Rule to Reverse Trial Court Decision in Favor of Cannabis Retail Business |
O'Toole Scrivo, LLC |
| Jan 29 2025 |
Florida HR Considerations: Marijuana in the Workplace |
Proskauer Rose LLP |
| Jan 28 2025 |
HHS-OIG Issues Favorable Opinion on Drug Manufacturer’s Free Genetic Testing, Counseling for Patients |
Barnes & Thornburg LLP |
